迷幻精神病学的勇敢新世界。
Psychedelic Psychiatry's Brave New World.
机构信息
Centre for Psychedelic Research, Department of Psychiatry, Imperial College London, London W12 0NN, UK.
Centre for Psychedelic Research, Department of Psychiatry, Imperial College London, London W12 0NN, UK.
出版信息
Cell. 2020 Apr 2;181(1):24-28. doi: 10.1016/j.cell.2020.03.020.
After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results. Outcomes of neuroscience and clinical research into 5-Hydroxytryptamine 2A (5-HT2A) receptor agonists, such as psilocybin, show promise for addressing a range of serious disorders, including depression and addiction.
在经过几十年的法律强制全球暂停对迷幻药物的研究后，针对精神疾病的迷幻药物研究正在取得令人兴奋的成果。对 5-羟色胺 2A（5-HT2A）受体激动剂（如裸盖菇素）的神经科学和临床研究结果表明，它们有望治疗一系列严重疾病，包括抑郁症和成瘾。
Zotero 插件